Mood, sleep, cravings, anxiety, and impulse control can shift for many reasons. A GLP-1 timeline helps separate dose context from stress, under-eating, alcohol, sleep debt, and life changes.
FDA and EMA reviews have not found evidence supporting a causal link between GLP-1 receptor agonists and suicidal thoughts/actions, while monitoring continues. That means content should avoid causal panic but still support practical symptom tracking.
| Track | Examples |
|---|---|
| Mood | Flat, anxious, irritable, low, normal, unusually activated. |
| Impulses | Gambling, alcohol, shopping, binge eating, scrolling, nicotine, risky choices. |
| Sleep and recovery | Sleep duration, HRV, resting heart rate, fatigue, exercise load. |
| Dose context | Dose day, increase week, restart, missed dose, GI symptoms. |